Skip to contentO
Oragenics Inc
O
OGENOragenics Inc Q3 2015 · 10-Q
Revenue$329.80K$329.80K+64.1% vs Q3 2014 Net Income-$1.86M-$1.86MN/M vs Q3 2014 EPS Diluted-$0.05-$0.05N/M vs Q3 2014 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,339,709N/M Free Cash Flowderived-$1,348,331N/M Margins · derivedGross margin0.0%−63.3 pt vs Q3 2014
Operating margin-565.8%−51.0 pt vs Q3 2014
Net margin-565.1%−52.9 pt vs Q3 2014
ended Sep 30, 2015 · filed Nov 6, 2015 · 37 d after period end